Clinical trials sponsored by Arrowhead Pharmaceuticals

Phase breakdown

Conditions studied

Recruiting trials led by Arrowhead Pharmaceuticals

• A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
  NCT06937203 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 16 locations
• A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
  NCT06700538 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 7 locations
• Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease
  NCT07221344 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 3 locations
• Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma
  NCT07241546 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 5 locations

Common questions

How many trials is Arrowhead Pharmaceuticals recruiting for?

Arrowhead Pharmaceuticals is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.